1. Chemosensitization and mitigation of Adriamycin-induced cardiotoxicity using combinational polymeric micelles for co-delivery of quercetin/resveratrol and resveratrol/curcumin in ovarian cancer.
- Author
-
Fatease AA, Shah V, Nguyen DX, Cote B, LeBlanc N, Rao DA, and Alani AWG
- Subjects
- Animals, Apoptosis drug effects, Cardiotoxicity diagnostic imaging, Cardiotoxicity physiopathology, Cell Line, Tumor, Cell Survival drug effects, Curcumin administration & dosage, Curcumin pharmacology, Drug Delivery Systems, Female, Humans, Inhibitory Concentration 50, Luminescent Measurements, Mice, Ovarian Neoplasms diagnostic imaging, Quercetin administration & dosage, Quercetin pharmacology, Resveratrol administration & dosage, Resveratrol pharmacology, Stroke Volume drug effects, Troponin I metabolism, Xenograft Model Antitumor Assays, Cardiotoxicity drug therapy, Curcumin therapeutic use, Doxorubicin adverse effects, Micelles, Ovarian Neoplasms drug therapy, Polymers chemistry, Quercetin therapeutic use, Resveratrol therapeutic use
- Abstract
This work looks to improve the efficacy of Adriamycin (ADR) while mitigating its cardiotoxicity using combinations of micellar resveratrol (R): quercetin (Q) (mRQ) or R: curcumin (C) (mRC) in healthy mice and ovarian cancer xenograft models. Ovarian cancer cells, ES2-Luc, or A2780ADR are inoculated in mice (n =4/group) and sorted into eight cohorts. Mice are treated weekly for 4 weeks with ADR, ADR+mRQ, ADR+mRC, or controls (saline, empty micelles, ADR+EM, mRQ, or mRC). To evaluate the degree of cardioprotection, serum is collected to determine the cardiac Troponin I (cTnI). Cardiac tissue is collected for morphological evaluation and evaluation of creatine kinase levels. Our results indicate that mRQ+ADR is statistically significant in tumor reduction in xenograft models. In healthy mice, the left ventricular ejection fraction and fractional shortening in the ADR treated group is most compromised. Co-administration of mRQ with ADR can reduce ADR dosing through chemosensitization while being cardioprotective., (Copyright © 2019 Elsevier Inc. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF